■ INTRODUCTION
Tissue hypoxia is a complicated condition in which O 2 demand exceeds supply and results in disrupted cellular metabolism. It can occur when vascular dioxygen supply is interrupted after stroke or myocardial infarction, or when a tumor exceeds the vascular diffusion limit for oxygen. Tumors that are hypoxic can be more resistant to traditional therapeutic strategies. Imaging agents that are selectively retained in hypoxic tissue can be detected using noninvasive molecular imaging techniques and have a role to play in increasing the understanding of hypoxia in tumor biology. Hypoxia imaging agents are also useful tools for clinicians when designing and assessing treatment regimes. 1 The molecular imaging technique of positron emission tomography (PET) relies on a positron-emitting molecule, a tracer that is administered to a patient, and the emitted radiation is detected by an external camera. A 2-nitroimidazole, labeled with positron-emitting fluorine-18, 18 F-fluoromisonidazole (FMISO; Figure 1a ), has been studied as a hypoxia imaging agent. 1−3 It is thought that FMISO is trapped preferentially in hypoxic tissue by virtue of reduction of the nitro functional group, followed by reaction of the reduced hydroxylamine with reactive biomolecules found inside cells. In normal cells, it is argued that any reduced intermediates are rapidly oxidized back to the original nitroimidazole, which is then capable of diffusing back out of the cell. Although FMISO has demonstrated considerable potential as a hypoxia imaging agent, it suffers from relatively slow cell uptake and poor clearance from normoxic tissue. 4−6 While the number of hospitals equipped with PET infrastructure is increasing, single photon emission computed tomography (SPECT) remains the major technique for nuclear medicine imaging. The most commonly used radioisotope for SPECT is technetium-99m ( 99m Tc), and unlike 18 F that requires a cyclotron for production of tracers, 99m Tc is readily available from commercial generators. The nuclear properties of 99m Tc (t 1/2 = 6.01 h, E γ = 141 keV) are ideally suited to diagnostic procedures. A hypoxia-selective 99m Tc radiopharmaceutical that utilizes the more commonly encountered imaging modality of SPECT could be an attractive alternative to 18 F based 2-nitroimidazole systems. Efforts to produce hypoxiaselective technetium complexes have focused on propylene amine oxime ligands (PnAO) with appended nitroimidazole functional groups such as [TcO(PnAO-1-(2-nitroimidazole)] (Figure 1b ). This complex selectively accumulates in hypoxic cells in vitro; however its use in vivo is limited by high blood uptake and extensive hepatobiliary excretion. 7−9 The {Tc V O} 3+ complex of a butylene amine oxime ligand, [TcO(BnAO)] (also referred to as [TcO(HL91)] or Prognox; Figure 1c ), does not contain a nitro functional group but does display some degree of hypoxia selectivity, although the origins of this specificity remain uncertain. 10−12 Peptide-based ligands containing a 2-nitroimidazole functional group for the {Tc V O} 3+ fragment have also been investigated. 13, 14 Bioreductive prodrugs that can undergo enzymatic reduction are generally classified within one of five categories: the nitroaromatics, quinones, aromatic/aliphatic N-oxides, or metal complexes. 15 Similarly to 2-nitroimidazoles, nitrobenzenecontaining agents are contained within the nitroaromatic subset. These molecules are under continuing investigation for their involvement in enzyme-catalyzed prodrug therapy, where endogenous enzymes activate (reduce) the nitro functional group to stimulate the formation of a cytotoxic, bioactive molecule. This is demonstrated by the hypoxiaselective antitumor arylmethyl quaternary mustard, N,N-bis(2-chloroethyl)-N-methyl-N-(2-nitrobenzyl)ammonium chloride (Figure 1d ), which undergoes reductively induced fragmentation reactions via a radical intermediate. 16, 17 Nitrobenzylcontaining rhenium and technetium complexes may be equally as effective as 2-nitroimidazole-based complexes.
An alternative to the {Tc V O} 3+ core is the fac-{Tc I (CO) 3 } + precursor. Seminal developments in synthetic methods that allow the preparation of technetium compounds of the type fac-[Tc(CO) 3 (H 2 O) 3 ] + under conditions amenable to radiopharmaceutical applications have stimulated the focus on this approach and reinvigorated research into targeted technetium radiopharmaceuticals. 18 The "tricarbonyl core" approach exploits the stability of the metal tricarbonyl core while manipulating the relatively labile water ligands to attach targeting vectors. A variety of mono-, bi-, and tridentate ligands can react with the fac-{Tc I (CO) 3 } + fragment and displace the substitutionally labile aquo ligands.
The lack of nonradioactive isotopes of technetium complicates exploratory chemical synthesis. Consequently, rhenium, the nonradioactive, group VII congener of technetium, is often used as a 99m Tc surrogate in developmental chemistry. Rhenium and technetium have similar ionic radii, and {M I (CO) 3 } + (M = Tc, Re) complexes are often isostructural. The interest in rhenium analogues also extends to the possibility of using the β − -emitting rhenium isotopes 186 Re (t 1/2 = 90.6 h, E max = 1.1 MeV, 91%) and 188 Re (t 1/2 = 17.0 h, E max = 2.1 MeV, 85%) for radiotherapeutic applications. 19 In this paper, we describe the synthesis and characterization of fac-{M I (CO 3 )} + (M = Re, 99m Tc) complexes with aromatic amine bi-and tridentate ligands containing nitroaromatic functional groups with a view to producing hypoxia-selective agents. Aromatic amines coordinate to the metal ion with rapid complexation kinetics, and the resulting complexes possess high stability. 18 Though much emphasis has focused on the stability of tridentate chelators, the [2 + 1] mixed-ligand option may also be a viable approach due to the strong-field nature of the fac-{M I (CO) 3 } + (M = Tc, Re) core. A potential advantage of [2 + 1] mixed-ligand complexation is that the apical [+1] site can be changed to modulate the physical characteristics of the compound such as the solubility, lipophilicity, and ultimately membrane permeability.
The use of a single tridentate ligand has potential benefits in the ease of radiochemical synthesis as well as enhanced complex stability. Dipicolylamine, 20−23 picolylamine monoacetic acid, 23−25 and iminodiacetic acid 23, 26, 27 are commonly used tridentate ligands to form complexes with fac-{M I (CO) 3 } + (M = Tc, Re), and a series of iminodiacetic acid-based ligands featuring 2-nitroimidazole functional groups have been investigated as potential hypoxia tracers. 26−29 In this study, a series of rhenium complexes containing either nitroaromatic or 2-nitroimidazole functional groups are prepared and characterized. The cell uptake of the rhenium compounds in both normoxia and under hypoxic conditions was investigated using inductively coupled plasma mass spectrometry (ICP-MS) and confocal fluorescence microscopy. The technetium-99m complexes have been prepared and characterized by comparison to the nonradioactive rhenium analogues and one example has been assessed in a hypoxic tumor model.
■ RESULTS AND DISCUSSION
Synthesis and Characterization of [2 + 1] MixedLigand Ligands and Complexes. Two potentially bidentate, 2-pyridylhydrazone ligands, HL 1 and HL 2 ( Figure 2 ), each bearing a nitro functional group, were prepared by condensation of 2-hydrazinopyridine with either p-nitrobenzaldehyde or m-nitrobenzaldehyde. The ligands were characterized by NMR spectroscopy, ESI-MS, and X-ray crystallography. + , can be prepared by heating [Re(CO) 5 Br] at reflux in water for 24 h. This more convenient method is moderately successful, but the relative insolubility of the [Re(CO) 5 Br] starting material in water and its hydrophobicity leads to a substantial loss in yield when working on smaller scales (ca. < 100 mg) as the rhenium pentacarbonyl bromide tends to coat glassware and require constant "washing" back into the reaction mixture. During the course of this work, we have developed a microwave heating method of producing fac-[Re(H 2 O) 3 (CO) 3 ] + in near quantitative yields that is equally effective on small scales as on larger scales. Commercially available [Re(CO) 5 Br] was suspended in water and the mixture sparged with nitrogen and subjected to microwave-assisted thermal heating for three intervals of 10 min to give clear solutions of fac-[Re(CO) 3 (Figure 4) .
Replacing the monodentate [+1] bromide ligand can lead to the modification of physical and biological properties of the metal and also produce complexes that are more resistant to substitution in vivo. It was of interest to use pyridine based ancillary [+1] ligands due to the ability of heterocyclic amines to form complexes that are resistant to substitution, and the use of 3-(dimethylamino)-1-propylamine (DMAPA) as an ancillary ligand was designed to dramatically change solubility and membrane permeability.
Initial synthesis used a high-boiling solvent, 1,2-dichlorobenzene, and an excess of ligand. A superior synthetic procedure involved the reaction of equimolar amounts of ligand, HL 1 or HL 2 , and tris-substituted fac-[Re(CO) 3 (X) 3 ] + (X = pyridine, 4-picoline, 3-(dimethylamino)-1-propylamine) in methanol via microwave irradiation for 20 min (Scheme 1). Crystals of fac-[Re(CO) 3 (L 1−2 )(X)], suitable for X-ray analysis, were formed following partial evaporation of the reaction mixture solvent, in yields of approximately 70% ( Figure 5 , Table 4 ). Replacing the monodentate bromide ligand with basic N-containing heterocycles, pyridine or 4-picoline, resulted in the isolation of neutral complexes with the deprotonation of the bidentate hydrazone ligand.
It is interesting to note that fac-[Re(CO) 3 (HL 1 )(pyridine)]-BPh 4 is the only complex to crystallize as the cationic species via protonation of the hydrazinic (N2) nitrogen ( Figure 5a) ; nonetheless deprotonation is easily induced by the addition of )(Br)] complexes and 2.212 Å for the N-heterocycle substituted complexes (Table 1) . Additionally, the Re−N1 distance is also consistently shorter for complexes with nitroaromatic coordination at the ancillary site, compared to the bromo-substituted rhenium complexes (2.22 vs 2.16 Å).
The N1−C7 sp 2 hybridized bond for the two nitro-bearing ligands (HL 
)(4-picoline)] with thermal ellipsoids shown at 50% probability. Hydrogen atoms, counterion, and solvent molecules have been omitted for clarity unless relevant. Å), while all other complexes consistently show slightly longer lengths (between 1.379 and 1.382 Å).
The 1 H NMR spectra of the ligand and complexes with an m-
were all as expected. For example, coordination of the metal ion to HL 2 results in a significant downfield shift in the resonance attributed to the proton attached to C2 (Figure 4b ), shifting from δ 8.47 ppm for HL 2 to δ 9.66 ppm for the complex fac-[Re(CO) 3 (L 2 )(4-picoline)]. Additionally, for all picoline, pyridine, and DMAPA complexes, a dramatic shift to a higher field for the resonance attributed to the CHN proton is observed. As this shift is not reflected in the bromo complexes, it can be assumed that the shielding effects of the nitrogen-containing moiety are substantial. . Hydrazinic proton shifts are not evident for the picoline, pyridine, or DMAPA complexes, and the absence of the hydrazinic υ(N−H) infrared stretch, which is apparent in the protonated complexes between ν ̅ 3182 and 2931 cm −1 , provides support that these complexes are deprotonated.
Infrared CH stretches for the monodentate pyridine ring and the azomethine are shifted to a slightly higher energy compared to the "free" ligand, which is consistent with the decrease in electron density within the rings and backbone, though overlap of the absorbances from the pyridine skeletal bands and υ(NO 2 ) stretches cause some obscurity.
The infrared spectra for fac-[Re(CO) 3 (H 2 O) 3 ] + and the trispicoline and tris-pyridine complexes consistently display two typical stretching bands for the facially orientated terminal tricarbonyl, υ(CO), moiety at ν ̅ 2040 and 1881 cm . All other complexes which deviate from C 3v symmetry show either two or three bands between ν ̅ 2016 and 1894 cm −1 in the typical carbonyl stretching region of compounds containing α-diimine ligands. 30 It is assumed that those complexes which display only two stretches have the middle band obscured by the stronger, broad stretch at the lower energy.
Electrochemical Studies. The electrochemical characteristics of the nitro-containing ligands (HL 1 and HL 2 ) and all [2 + 1] mixed-ligand complexes were studied by cyclic voltammetry in acetonitrile. Potentials are quoted relative to the ferrocene/ferrocenium couple, where E 0 ′ is designated as +0.40 V vs SCE. 31 The cathodic region was investigated for all compounds in order to establish the location of significant redox processes. Comparative redox potentials were examined against the para-methoxy substituted complex fac-[Re-(CO) 3 )Br], two reduction waves are observed within the range 0.0 and −1.15 V. The first peak is generally irreversible and the second quasi-reversible; this is a common observation for nitro-aromatic compounds, 32, 33 although this pattern was not seen for either of the nitro-based ligands which display only one quasi-reversible peak.
Complexes containing the nitro substituent in the para position of the ligand (L 1 ) consistently display higher reduction potentials and more complex voltammograms than the metanitro (L 2 ) species. The broadness of the first reduction wave for fac-[Re(CO) 3 (L 1−2 )Br] and fac-[Re(CO) 3 (L 2 )(X)] (X = pyridine, 4-picoline) indicates that multiple electron processes are occurring. This is further confirmed by the occurrence of three distinct reduction peaks for fac-[Re(CO) 3 (L 1 )(pyridine)] between −0.80 and −1.18 V ( Table 2) .
It is worth noting that complexes with nitrogen substituted [+1] ancillary ligands are deprotonated at the hydrazinic nitrogen in solution, if not confirmed by the crystal structure data but also by the change in color to the analyte solution to deep red. This indicates that the first cathodic peak most likely involves a proton-coupled reduction, which, though ligand based, is affected by coordination to the metal to give an electrochemical−chemical based process. The latter, quasi-reversible cathodic peak is assigned to an initial one-electron reduction of the nitro conjugate base to the radical anion. 5, 7, 32, 34 All quasi-reversible reduction processes show a peak separation (ΔE p ) value between 58 and 64 mV indicating a one-electron reversible process. Peak current ratios (i p /i a ) are more variable, with ratios for the complex quasireversible reduction processes between 0.74 and 1.38. All quasireversible reduction processes for the rhenium complexes were measured at scan rates of 50, 100, 200, and 300 mV s −1 and produce linear correlations (R 2 ≈ 0.99) when plotted against the square root of the scan rate (v 1/2 ). The redox chemistry for the meta-nitro ligand (HL 2 ) compared to corresponding rhenium complexes displays a slight shift to higher potential values upon coordination, whereby the uncomplexed ligand shows an E pc value of −1.18 V and the complexes have reduction potentials of −1.14 V ( Figure 6 ); this is tentatively assigned to the slightly electronwithdrawing nature of the metal center. 7 For similar rhenium compounds, the metal-centered reduction assigned to Re 1 /Re 0 is between −1.2 and −1.6 V and devoid of an oxidation wave (CH 3 CN, 100 mM tetrabutylammonium perchlorate). 35 It is most likely that, within the observed window, experimental potentials are not inclusive of the reduction of rhenium. Furthermore, the reduction of rhenium(I) to rhenium(0) is not likely to occur in the cellular environment.
Synthesis and Characterization of Tridentate Ligands and Complexes. The preparation of the ligands involved in the formation of the two tridentate complexes fac-[Re-
] took advantage of the previously reported synthesis of 2-nitroimidazole by initial diazatization from 2-aminoimidazole sulfate, and subsequent nitration was performed using copper sulfate as a catalyst. 36 Bromoalkylation of the potassium salt of the nitroimidazole was obtained according to published procedure using 18-crown-6 in anhydrous acetonitrile to afford the desired bromobutylimidazole (1). A similar procedure for the formation of the neutral complex fac-[Re(CO) 3 (L 6 )] was used; however synthesis of the ligand, HL 6 , involved the initial preparation of 2 via condensation of 2-picolylamine and ethylbromoacetate followed by Kugelrohr distillation and reaction with the bromoalkylated nitroimidazole, 1. In situ hydrolysis of the ester using sodium hydroxide and thermal heating at 120°C with [Re(CO) 5 Cathodic peak potential corresponding to the first reduction step. Where there is no value given, the first cathodic peak is quasireversible, and values are provided in the proceeding column. c Cathodic peak potential corresponding to the second quasi-reversible (qr) reduction step.
d Peak current ratio of second quasi-reversible cathodic peak.
e ΔE p = |E pc − E pa | of quasi-reversible peak (voltage separation between current peaks).
f Potentials in brackets indicate a visibly distinct reduction potential between or after indicated reduction peaks. Abbreviations: pc = cathodic potential, pa = anodic potential, qr = quasi reversible. 1 H} NMR spectra, particularly for the equivalent methylene protons adjacent to the pyridine rings which shift from a singlet resonance at δ 3.74 ppm for the ligand to δ 4.60 ppm for the complex; this is most likely due to the deshielding effects of the rhenium center. Similar patterns are observed for the HL 6 ligand and complex. Evidence advocating the formation of the neutral complex shows transformation of the methylene protons adjacent to the pyridine and carboxylate from two singlet resonances to a distinctive set of four doublets indicating geminal coupling ( 2 J HH = 16 Hz); this does not occur for the cationic complex.
Inorganic Chemistry
Crystals suitable for analysis by X-ray crystallography for fac-[Re(CO) 3 (L 5 )]BPh 4 were grown from a concentrated solution of the compound in methanol ( Figure 7 ). The complex crystallizes in the triclinic space group, P1̅ , and displays characteristic crystallographic parameters, bond lengths and angles for a tricarbonyl, tridentate rhenium complex (Table 3,  Table 4 ). 25, 26, 39 Cyclic voltammetry shows a reduction peak pattern similar to those seen for the [2 + 1] mixed-ligand complexes. A quasireversible cathodic peak was observed at −1.10 and −1.11 V for both nitro ligand species, L 5 and L 6 Et, respectively. The quasireversible reduction wave for the complexes is shifted to −1.08
. No initial, nonreversible reduction peak was observed for the complexes, suggesting that any other reduction processes occur outside of the observed window.
UV−Visible and Fluorescence Studies. The absorption spectra of both HL 1 and HL 2 dissolved in acetonitrile display two peaks in the UV region, HL 1 at λ 387 and 254 nm and HL 2 at λ 327 and 225 nm, and are assigned to π → π* transitions. In the metal complexes featuring a meta-nitro functional group, MLCT transitions at λ 463−469 nm are evident that shift to λ 520−528 nm for complexes possessing the para-NO 2 functional group. These values reflect those of similar low-valent, rhenium complexes, albeit more often as the α-diimine rather than the hydrazone functionality. 40 The low energy absorbance demonstrates the strong π acceptor nature of the ligands, and the bathochromic shift of the para-NO 2 complexes implies the delocalization of electron density caused by the para substituent.
Complexes where the pyridyl-hydrazone is deprotonated and contains the para- (3) 16.4614 (2) 11.99950 (10) 8.050 (2) 9.6870(3)
10.1399 (5) 5.5373 (2) 7.2712 (5) 10.010 (2) 9.21900 (10) 7.75170 (10) 22.9282 (2) 15.143 (4) 11.9283 (3) c (Å)
11.9298 (6) 16.7262 (6) 16.6373 (6) 13.421 (3) 14.1755 (2) 16.0826 (2) 14.58840 (10) 32.934 (8) 17 4 complexes by the addition of triethylamine augmented emission intensity, which indicates that deprotonation for these complexes is not complete in acetonitrile despite the immediate changes in color from yellow to purple without the addition of a base.
The luminescence properties of such compounds may be useful for developmental investigations into cell localization and, due to their low energy emissions, are particularly beneficial to distinguishing between endogenous fluorophores, which typically emit at much higher energies.
Confocal Fluorescence Microscopy and ICP Mass Spectrometry. The luminescence properties of these complexes are useful for investigating cell uptake and intracellular localization using confocal fluorescent microscopy, as their relatively low energy excitation profiles and large Stokes' shifts allow images to be acquired with little autofluorescence due to endogenous fluorophores.
42−45
A proof-of-concept study identified that it was possible to monitor cell uptake and distribution of the picoline-derived fac-[Re(CO) 3 (L 1 )(4-picoline)] complex within a HeLa cancer cell line with the aid of fluorescence microscopy. The cells were exposed to increasing concentrations of the compound (5−50 μM) for 30 min, and fluorescence was measured following excitation at a wavelength of 520 nm. The complex localizes primarily within the cytosol with no uptake in the nucleus. The complex also accumulated in puncta indicative of cytosolic vesicles, and the cells retained their morphology during the 30 min incubation (Figure 9 ). The cellular permeability and retention of fac-[Re-(CO) 3 SH-(SY5Y) cells were cultivated to approximately 60% confluency, then transferred to a sealed GasPak EZ anaerobe container system with indicator and cultivated overnight to 80− 90% confluency before treatment to induce hypoxia-like conditions. After the treatment solutions were prepared and 47 Each mouse had different tumor volumes: 400, 600, and 1100 mm 3 for mouse 1, 2, and 3, respectively. Tumor uptake is not evident for the 400 mm ) with the hypoxia tracer 18 F-FMISO also revealed little penetration of the tracer into the tumor but a small amount of uptake of the tracer around the outer edge of the necrotic core ( Figure 13 ). The SK-RC-52 tumor model has been well characterized, and tumor size does serve as a useful guide to tumor hypoxia, but it is acknowledged that hypoxia cannot be predicted by tumor size alone. 47 3 (L 1−4 )(X)] (X = 4-picoline, pyridine, DMAPA) were synthesized by microwave-assisted thermal heating with short reaction times to give products in good yields and high purity. These complexes were characterized by mass spectroscopy, NMR, IR, UV−visible and fluorescence spectroscopy, and Xray crystallography. Electrochemical studies investigated the relative inductive influences and resonance effects of the assorted ligand substituents (H, OCH 3 , m-NO 2 , p-NO 2 ), in addition to highlighting the complicated mechanism of reduction of the nitrobenzene-containing species. Cyclic voltammetry reveals reductive processes for the nitro-bearing rhenium complexes with E 0 ′ values between −0.6 and −1.1 V that are within biologically accessible electrochemical potentials. Crystallographic studies show that ligands HL ■ EXPERIMENTAL SECTION General Procedures. All reagents and solvents, unless otherwise stated, were purchased from standard commercial sources and were used as received. Anhydrous ethanol (EtOH) was dried over magnesium ethoxide under a nitrogen environment. N,N-dimethylformamide (DMF) was distilled and dried over magnesium sulfate and stored over 4 Å molecular sieves. Acetonitrile (CH 3 CN) was dried over K 2 CO 3 , distilled, and stored over 3 Å molecular sieves. All reactions were undertaken under inert conditions unless otherwise indicated. A Biotage Initiator Sixty EXP 2.0 Microwave Reactor was utilized for all microwave-assisted reactions. Thin-layer chromatography (TLC) was performed on Merck aluminum backed 2-μm-thick silica gel plates (60 GF 254 ) and were visualized under λ 254 nm UV light or stained with 20% w/v phosphomolybdic acid in ethanol, iodine dip, or 20% w/v copper chloride in acetone where relevant. Column chromatography was performed on silica gel (Kieselgel 60, 230−400 mesh) using the indicated solvent system. Nuclear Magnetic Resonance (NMR) spectra were acquired on a superconducting Varian-FT-NMR 500 spectrometer (Varian, California, USA). All NMR were acquired at 25°C. 1 H and 13 C{ 1 H} chemical shifts were referenced to residual solvent peaks and are quoted in parts per million relative to TMS. Mass Spectra (MS) were recorded on an Agilent 6220 Q-TOF LC/MS (Agilent, California, USA) mass spectrometer and/or a Waters-Micromass QuattroII triple quadrupole electrospray ionization mass spectrometer. Cyclic voltammograms were recorded on an AUTOLAB PGSTAT100 electrochemical workstation using GPES V4.9 software. A glassy-carbon working electrode, platinum wire counter electrode, and Ag/Ag + (silver wire immersed in 0.01 M AgNO 3 /CH 3 CN) reference electrode were utilized for all measurements. Measurements were taken in deoxygenated, anhydrous CH 3 CN with 0.1 M supporting electrolyte, [NH 4 ][BF 4 ], and 1.0 mM analyte unless otherwise specified. Each solution was measured at ambient temperature, and the cell was kept under a N 2 atmosphere throughout the experiment. Cathodic peak potentials (E pc ) and half-wave potential (E 0 ′) were measured relative to an internal reference ferrocenium/ ferrocene (Fc + /Fc) redox couple, where E 0 ′ was designated as +400 mV vs a saturated calomel electrode (SCE) in acetonitrile. 31 Analytical Reverse Phase High Performance Liquid Chromatography (RP-HPLC) was undertaken using an Agilent 1100 Series HPLC System using a Zorbax Eclipse XDB-C18 column (4.6 × 150 mm, 5 μm) at a flow rate of 1 mL min UV−visible absorption spectra were recorded on a Shimadzu UV-1650PC UV−visible spectrophotometer using UVPC v3.9 software. Emission spectra were obtained on a Varian CARY Eclipse fluorescence spectrophotometer. Both absorption and emission spectra measurements were performed in capped quartz cuvettes in THF or CH 3 CN.
Inorganic Chemistry
Infrared spectra (IR) were recorded neat on a PerkinElmer Spectrum One FT-IR spectrometer with a zinc selenide/diamond universal ATR 60 sampling accessory, as a thin film using cm −1 as units of measurement. Melting points were determined using an EZ-Melt MPA 120 Automated Melting Point Apparatus from Stanford Research Systems and are uncorrected. Analytical radio-HPLC was performed using a Shimadzu 10 AVP UV−visible spectrophotometer (Shimadzu, Kyoto, Japan) with two LC-10ATVP solvent delivery systems for solvents A and B. Peak separation was achieved using a Nacalai Tesque Cosomosil 5C18-AR Waters column (4.6 × 150 mm, 5 μm; Nacalai Tesque, Kyoto, Japan) at 1 mL min −1 . System C: Gradient elution of buffer A (0.1% TFA in H 2 O) and buffer B (0.1% TFA in CH 3 CN) from 0 to 100% B to A, over 20 min and UV detection at λ 254 nm.
Human blood samples were centrifuged with a Heraeus Labofuge 6000 centrifuge at 3000g for 10 min (Heraeus, Hanau, Germany). Radioactivity readings for serum stability studies were taken with a Capintec CRC-35R dose calibrator (Capintec, New Jersey, USA) and were measured in MBq.
Centrifugation of radioactive compounds was undertaken using an Eppendorf 5415 D centrifuge (Eppendorf, Hamburg, Germany). Partition coefficient data were collected with a PerkinElmer, Wizard 1470 (PerkinElmer, Massachusetts, USA) automatic γ counter, which measured the radioactive decay of each sample in counts per minute (cpm).
SPECT images were obtained using a Mediso nanoScan SPECT/ CT (and MRI subsystem; Mediso Medical Imaging Systems, Budapest, Hungary) equipped with a multipinhole (M 3 ) collimator. Visualization and evaluation of SPECT data was carried out using PMOD fusion software (PMOD technologies, Switzerland). Organ uptake was initially expressed as counts per voxel and then calculated as the percentage of injected dose (%ID) and percentage of injected dose per gram (%ID/g) volume. Animals were imaged at the Australian Cancer Research Foundation (ACRF) Centre for Translational Cancer Therapeutics and Imaging.
Syntheses.
[Re(CO) 5 OTf], 50 1H-imidazol-2-amine sulfate, 51 potassium 2-nitro-1H-imidazolide, 37 1-(3-bromopropyl)-2-nitro-1H-imidazole, 37 and N-(2-pyridylmethyl)aminoethyl acetate 52 were synthesized according to previously reported procedures. Ligands HL 1 and HL 2 are known compounds and their spectroscopic details are available from the literature; 53, 54 however NMR spectral data and melting points vary significantly from values obtained for this research, therefore full spectral analysis has been provided. HL
1
. To 2-hydrazinopyridine (3.00 g, 27 mmol) in ethanol (40 mL) was added 4-nitrobenzaldehyde (4.15 g, 27 mmol). The resulting suspension was stirred for 4 h at RT. The precipitate was collected via vacuum filtration and washed with cold ethanol (3 × 10 mL) and diethyl ether (3 × 10 mL). The solid was purified by column chromatography (CH 2 Cl 2 /CH 3 OH, 95:5), and the desired fractions were recrystallized from hot dichloromethane to give orange stick needles (5.02 g, 77%). HL 2 . The procedure is as that for HL 1 , except using 2-hydrazinopyridine (3.00 g, 27 mmol), ethanol (40 mL), and 3-nitrobenzaldehyde (4.15 g, 27 mmol). The solid was recrystallized from hot chloroform to afford a yellow fluffy solid (4.81 g, 74%). , except using 2-hydrazinopyridine (0.81 g, 7.4 mmol), ethanol (10 mL), and 4-methoxybenzaldehyde (0.89 mL, 7.4 mmol). The collected precipitate was sufficiently clean to proceed without further purification and was obtained as a white fluffy solid (1.20 g, 72%) . 1 , except using 2-hydrazinopyridine (0.80 g, 7.1 mmol), ethanol (10 mL), and benzaldehyde (0.82 mL, 7.1 mmol). The collected precipitate was sufficiently clean to proceed without further purification and was obtained as a pale yellow solid (1.0 g, 72%). Br. This compound was prepared by a modification of a previously reported procedure. 55 To bromopentacarbonyl rhenium(I) (0.40 g, 0.98 mmol) was added degassed Milli-Q water (10 mL). The suspension was subjected to microwave heating for 10 min at 150°C. The reaction mixture was vigorously shaken then resubjected under the same conditions (×2). The solution was filtered hot and reduced in vacuo to afford a pale green powder (0.39 g, 98%). IR:
OTf. This compound was prepared by a modification of a previously reported procedure. 55, 56 To pentacarbonyl(trifluoromethanesulfonato) rhenium(I) (0.30 g, 0.63 mmol) was added degassed Milli-Q water (6.3 mL). The suspension was subjected to microwave heating for 15 min at 155°C. The reaction mixture was stored as a 0.1 M solution (approx.) in water.
fac-[Re(CO) 3 (pyridine) 3 ]OTf. This compound was prepared by a modification of a previously reported procedure. 56 To pentacarbonyl-(trifluoromethanesulfonato) rhenium(I) (0.19 g, 0.31 mmol) purged with N 2 was added degassed pyridine (4 mL). The solution was subjected to microwave conditions at 150°C for 15 min. The pyridine was reduced to approximately 1/4 under a high vacuum and diethyl ether (4 mL) added and stirred vigorously, whereby a white solid precipitated. The solid was filtered and washed with copious amounts of cold diethyl ether to afford white crystals (0.22 g, 83%). fac-[Re(CO) 3 (4-picoline) 3 ]OTf. This compound was prepared by a modification of a previously reported procedure. 56 Freshly distilled 4-p i c o l i n e ( 2 m L ) w a s a d d e d t o p e n t a c a r b o n y l -(trifluoromethanesulfonato) rhenium(I) (0.16 g, 0.33 mmol) and subjected to microwave conditions at 150°C for 15 min (×2). The solution was cooled to RT, and diethyl ether (6 mL) was added. The resulting precipitate was filtered and washed with cold diethyl ether to afford a white powder (0.18 g, 78%) . 1 3 ]OTf (0.1 g, 0.14 mmol) was dissolved in degassed, anhydrous CH 3 OH (3 mL) and added to the suspension. The reaction mixture was subjected to microwave irradiation at 155°C for 2 × 10 min. The solution was cooled, and the resultant precipitate was collected via vacuum filtration. The filtrate was collected and reduced in vacuo to approximately 1/2 the initial volume, followed by the addition of Et 2 O to yield a second crop of the desired product. A forest-green, crystalline solid was obtained (0.07 g, 80%). 
; 0.07 g, 0.19 mmol) in methanol (5 mL) was subjected to microwave irradiation for 15 min at 120°C. The solution was reduced in vacuo, and a concentrated solution of sodium tetraphenylborate (0.5 g, 1.4 mmol) in CH 3 OH (1 mL) was added. An off-white solid precipitated out of solution and was collected via vacuum filtration (0.13 g, 73%). Crystals of X-ray crystallographic quality were grown via slow evaporation of the solid dissolved in acetonitrile. 1 Et. Ethyl N-(2-pyridylmethyl)amino acetate (0.09 g, 0.43 mmol; 2) was added to a solution of 1-(3-bromopropyl)-2-nitro-1H-imidazole (0.10 g, 0.43 mmol; 1) in dry CH 3 CN (7 mL) and N,N-DIPEA (0.10 mL, 0.6 mmol). The reaction was heated to reflux overnight, then cooled and concentrated in vacuo. Purification by column chromatography (EtOAc/hexane, 96:4) afforded clear oil (0.03 g, 21% The mixture was shaken for 3 min; then the layers were left to separate. An aliquot of the organic layer (0.9 mL octanol) was added to freshly prepared 0.1 M PBS (0.9 mL), and each phase was presaturated with the other phase and shaken for 3 min. The mixture was centrifuged (5 min, 13 200 rpm) and aliquots (0.5 mL) from the two separate layers (aqueous and organic) taken for analysis of the radioactive decay. All samples were prepared and measured in triplicate.
For serum stability studies, 20 mL of blood from a healthy male was centrifuged (10 min, 3000 rpm) to separate blood plasma and red blood cells. The plasma was transferred to a separate vial and the red blood cells discarded. An aliquot of plasma (0.6 mL) was added to labeled compound fac-[ 99m Tc(CO) 3 (L
5
)] + (0.15 mL), the radioactivity monitored, and the mixture then incubated at 37°C. Aliquots (0.1 mL) of the mixture were removed from heating at 10 min and every 2 h following (over 6 h), and acetonitrile (0.1 mL) was added to the serum/tracer mix to precipitate serum proteins. The suspension was shaken for 5 min, then centrifuged (5 min, 13 200 rpm). The radioactivity of the supernatant and pellet was recorded. The supernatant (20 μL) was analyzed by analytical RP-HPLC (System C) for UV and radioactivity analysis and the pellet washed with acetonitrile (3 × 0.1 mL), and the radioactivity levels were again recorded (radioactivity levels of the pellet were negligible).
Confocal Fluorescent Microscopy. Human carcinoma HeLa cells were grown on poly-L-lysine (PLL) coated coverslips and incubated at 37°C (95% air, 5% CO 2 ). When cells had reached approximately 80% confluency, they were treated with 5, 10, 25, and 50 μM solutions of fac-[Re(CO) 3 (L 1−2 )(4-picoline)] in DMSO, λ ex = 520 nm. Cell treatments were for 30 min. Cells were then rinsed with 1% PBS and fixed with 4% (w/v) paraformaldehyde for 20 min at ambient temperature. Following fixation, cells were rinsed twice with 1% PBS and mounted onto glass slides using DAKO fluorescence mounting medium, and images were collected. Images of the cells were collected using an Olympus FV1000 IV81 confocal microscope. Cellular Assays. Cell uptake studies were carried out with the assistance of Dr. Christine Schieber and Ms. Irene Volitakis. Compounds were prepared as 10 mM stock solutions in culturegrade DMSO, and the control compound [Re(CO) 5 OTf] was prepared as a 10 mM stock solution in Milli-Q water. To each complex sample (50 μL) was added warmed, serum-free media (DMEM/F12 + P/S + NEAA + HEPES, 50 mL) for a final media solution concentration of 10 μM.
SH-(SY5Y) cells were grown continuously and passaged at regular intervals. Cells were removed from the tissue culture flask once 90% confluent and then grown in Petri dishes until approximately 60% confluency had been reached. Half the Petri dishes were placed in a BD GasPak EZ gas generating chamber with two activated gasgenerating sachets (BD GasPak EZ ref: 260001, Anaerobe Container System with Indicator) for 16 h. Low oxygen was confirmed for each assay as per the manufacturer's instructions.
For nonhypoxic (normoxic) cells, media were aspirated off the cells that were not in the anaerobic chamber and replaced with 10 mL of the media/complex solution (per plate in quadruplets). The cells were then incubated for 60 min at 37°C; DMSO was used as a vehicle control whereby cells were treated and incubated under the same conditions. For oxygen-depleted (hypoxic) cells, Petri dishes were removed from the anaerobic container system, and the existing media were replaced with fresh media solutions, which had been deoxygenated with N 2 gas over 10 min. Freshly prepared treatment solution (10 μM media/complex) was also degassed and then added to the cells after removal of the media. Cells were again placed in the GasPak EZ container with three new GasPak bags and incubated for 60 min at 37°C; DMSO was used as a vehicle control whereby cells were treated and incubated under the same conditions. Cells were scraped into the media and transferred into 15 mL Eppendorf tubes, which were centrifuged for 3 min (1500 rpm). The supernatant was removed and the pellet washed with PBS (2 × 5 mL). The cell pellet was resuspended in 1 mL of PBS and 100 μL removed for a BCA protein assay. The remaining mixture was centrifuged for 3 min (1500 rpm) and the PBS supernatant discarded. Cell pellets were stored at −20°C.
Rhenium levels were measured using a Varian UltraMass ICP-MS instrument and quoted relative to protein measured by bicinchoninic acid (BCA) protein assay. BCA protein assay was undertaken via a 10-fold dilution (with PBS) of the 100 μL cell-pellet/PBS mixture acquired earlier. A solution of BCA−reagent mixture, consisting of reagent A and reagent B (50:1), was prepared. Working solutions and standards (25 μL) were pipetted into 96-well microplates, followed by the addition of BCA−reagent (200 μL per well). The plates were covered in foil and incubated at 25°C for 30 min, and the absorbance was read at λ 562 nm for the colorimetric detection and quantitation of total protein in the cells.
Animal SPECT Imaging Studies with fac-[ 99m Tc(CO) 3 (L
. All animal experiments were approved by the Austin Hospital animal ethics committee. SPECT/CT studies involved the same labeling procedure as covered above, except that half the amount of radioactivity was used (approximately 50 MBq) per sample. SK-RC-52 tumors were first grown by injecting suspensions of 6 × 10 6 of SK-RC-52 tumor cells in saline subcutaneously into the flank of the three BALB/c nude mice. Tumours were allowed to grow to a size of about 300 mm 3 , then cut into 40 mm 3 pieces and transplanted into the shoulder of the BALB/c nude mice. Imaging was undertaken when the tumors were 400 mm 3 + respectively administered in 0.1 M PBS and 2% ethanol. Animals were anaesthetized with 5.0% isoflurane in air for induction and 2.5% isoflurane in air while the animal was on the scanning bed, with a Minerva Biovet animal imaging system. The Minerva Biovet system also provided a temperature-stabilized environment for the animals during the induction and imaging stages and respiration rate was monitored. A 10 min static frame was acquired for all three mice 2 h post injection. Images were reconstructed using a pinhole MLEM algorithm. FMISO was produced at Austin Health following a previously reported procedure. 57 ■ ASSOCIATED CONTENT * S Supporting Information
